A Phase I, Double-blind, Placebo-controlled, Randomized, Multiple-dose, Dose-ascending Study to Evaluate the Safety, Tolerability, Pharmacokinetics and to explore Pharmacodynamic trends after oral administration of TRC150094 in Overweight/Obese Male and Female Subjects with other non traditional CV risk factors.

Trial Profile

A Phase I, Double-blind, Placebo-controlled, Randomized, Multiple-dose, Dose-ascending Study to Evaluate the Safety, Tolerability, Pharmacokinetics and to explore Pharmacodynamic trends after oral administration of TRC150094 in Overweight/Obese Male and Female Subjects with other non traditional CV risk factors.

Completed
Phase of Trial: Phase I

Latest Information Update: 02 Sep 2016

At a glance

  • Drugs TRC 150094 (Primary)
  • Indications Obesity
  • Focus Adverse reactions
  • Sponsors Torrent Pharmaceuticals
  • Most Recent Events

    • 06 Dec 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top